• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对X连锁低磷血症成人患者的循证物理治疗处方

An Evidence-based Physical Therapy Prescription for Adults With X-linked Hypophosphatemia.

作者信息

Kanamalla Karthik, Fuchs Rebekah, Herzog Casey, Steigbigel Keith D, Macica Carolyn M

机构信息

Quinnipiac University, Frank H. Netter MD School of Medicine, Department of Medical Sciences, North Haven, Connecticut 06518, USA.

Quinnipiac University, School of Health Sciences, Department of Physical Therapy, North Haven, Connecticut 06518, USA.

出版信息

J Endocr Soc. 2022 Jun 18;6(8):bvac094. doi: 10.1210/jendso/bvac094. eCollection 2022 Aug 1.

DOI:10.1210/jendso/bvac094
PMID:35795809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9249973/
Abstract

CONTEXT

X-linked hypophosphatemia (XLH) is a rare and progressive metabolic phosphate-wasting disorder characterized by lifelong musculoskeletal comorbidities. Despite considerable physical disability, there are currently no disease-specific physical therapy (PT) recommendations for XLH designed to improve engagement and confidence in performing activities of daily living (ADL).

OBJECTIVE

The objective of this patient-centered study was to develop an evidence-based PT program to address gaps in the management of adult XLH without imposing unintended harm.

METHODS

Creation of the program was informed by a prior controlled clinical study to evaluate the physical and functional effect of XLH on adulthood, and guided by the physical presentation of participants, subjective data and patient goals acquired at intake, and by performance on multiple active range of motion (ROM) movements from the standing position. A weekly standardized interview process was used to assess progression of physical and functional abilities, gains and concerns, and to obtain timely feedback to inform future exercise modifications. Outcomes were evaluated using validated functional tools and subjective data obtained throughout the study.

RESULTS

A remote 12-week PT program was created based on collected data. Open and closed kinetic-chain exercises were developed and implemented. Functional improvements were documented, and weekly surveys indicated improved abilities and confidence to engage in ADL. Minimal improvements were observed in active upper and lower extremity ROM, reflective of substantial bony restrictions characteristic of XLH.

CONCLUSION

This study represents the first disease-specific PT recommendations for XLH to mitigate the unique physical challenges of the adult disorder that can be modified to adapt to the current progression status of the adult disorder.

摘要

背景

X连锁低磷血症(XLH)是一种罕见的进行性代谢性磷酸盐消耗性疾病,其特征是终身存在肌肉骨骼合并症。尽管身体残疾严重,但目前尚无针对XLH的特定疾病物理治疗(PT)建议,旨在提高参与度和进行日常生活活动(ADL)的信心。

目的

这项以患者为中心的研究的目的是制定一项基于证据的PT计划,以解决成人XLH管理方面的差距,同时避免造成意外伤害。

方法

该计划的制定参考了先前一项对照临床研究,以评估XLH对成年期的身体和功能影响,并以参与者的身体表现、摄入时获得的主观数据和患者目标,以及站立位多个主动活动范围(ROM)动作的表现为指导。采用每周标准化访谈流程评估身体和功能能力的进展、收获和担忧,并获得及时反馈以指导未来的运动调整。使用经过验证的功能工具和整个研究过程中获得的主观数据评估结果。

结果

根据收集的数据创建了一个为期12周的远程PT计划。开发并实施了开链和闭链运动。记录了功能改善情况,每周调查表明参与ADL的能力和信心有所提高。在主动上肢和下肢ROM方面观察到最小程度的改善,这反映了XLH特有的严重骨质限制。

结论

本研究代表了首个针对XLH的特定疾病PT建议,以减轻成人疾病独特的身体挑战,该建议可进行调整以适应成人疾病的当前进展状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a145/9249973/45600d5c6a86/bvac094_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a145/9249973/5350c1b6925e/bvac094_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a145/9249973/45600d5c6a86/bvac094_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a145/9249973/5350c1b6925e/bvac094_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a145/9249973/45600d5c6a86/bvac094_fig2.jpg

相似文献

1
An Evidence-based Physical Therapy Prescription for Adults With X-linked Hypophosphatemia.针对X连锁低磷血症成人患者的循证物理治疗处方
J Endocr Soc. 2022 Jun 18;6(8):bvac094. doi: 10.1210/jendso/bvac094. eCollection 2022 Aug 1.
2
Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia.X 连锁低磷血症成人的骨关节炎、骨赘和肌腱末端病影响生物力学功能。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1798-814. doi: 10.1210/clinem/dgaa064.
3
What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review.与传统疗法相比,抗成纤维细胞生长因子23(FGF23)抗体布罗索尤单抗对成人X连锁低磷血症表现的益处有哪些?一项综述。
Ther Adv Rare Dis. 2022 Feb 21;3:26330040221074702. doi: 10.1177/26330040221074702. eCollection 2022 Jan-Dec.
4
Physical function and physical activity in adults with X-linked hypophosphatemia.X 连锁低磷血症成人的身体功能和身体活动。
Osteoporos Int. 2022 Jul;33(7):1485-1491. doi: 10.1007/s00198-022-06318-w. Epub 2022 Feb 5.
5
Asia-Pacific Consensus Recommendations on X-Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care.《亚太地区X连锁低磷血症共识推荐:诊断、多学科管理及从儿科到成人护理的过渡》
JBMR Plus. 2023 May 1;7(6):e10744. doi: 10.1002/jbm4.10744. eCollection 2023 Jun.
6
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey.X连锁低磷血症的终身影响:疾病负担调查结果
J Endocr Soc. 2019 May 7;3(7):1321-1334. doi: 10.1210/js.2018-00365. eCollection 2019 Jul 1.
7
Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH).优化 X 连锁低磷血症(XLH)患儿和青少年长期骨骼肌肉健康的潜在影响。
Orphanet J Rare Dis. 2022 Jan 31;17(1):30. doi: 10.1186/s13023-021-02156-x.
8
Impaired Physical Performance in X-linked Hypophosphatemia Is not Caused by Depleted Muscular Phosphate Stores.X 连锁低磷血症患者的体力活动受损并非由肌肉磷酸盐储备枯竭引起。
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1634-1645. doi: 10.1210/clinem/dgad210.
9
Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study.探讨 X 连锁低磷血症的负担:一项欧洲多国定性研究。
Qual Life Res. 2020 Jul;29(7):1883-1893. doi: 10.1007/s11136-020-02465-x. Epub 2020 Mar 11.
10
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.国际 X 连锁低磷血症(XLH)登记处:基线人口统计学、遗传学和临床数据的首次中期分析。
Orphanet J Rare Dis. 2023 Sep 27;18(1):304. doi: 10.1186/s13023-023-02882-4.

引用本文的文献

1
Factors associated with impaired physical functionality in X-linked hypophosphatemia.与X连锁低磷血症患者身体功能受损相关的因素。
JBMR Plus. 2025 Feb 2;9(4):ziaf018. doi: 10.1093/jbmrpl/ziaf018. eCollection 2025 Apr.
2
Qualitative analysis of pain impact in adult patients with X-linked hypophosphatemia.X连锁低磷血症成年患者疼痛影响的定性分析
JBMR Plus. 2025 Jan 23;9(4):ziaf012. doi: 10.1093/jbmrpl/ziaf012. eCollection 2025 Apr.

本文引用的文献

1
Patient Satisfaction for Telehealth Physical Therapy Services Was Comparable to that of In-Person Services During the COVID-19 Pandemic.在新冠疫情期间,远程医疗物理治疗服务的患者满意度与面对面服务相当。
HSS J. 2020 Nov;16(Suppl 1):10-16. doi: 10.1007/s11420-020-09800-5. Epub 2020 Oct 19.
2
Giving Credence to the Experience of X-Linked Hypophosphatemia in Adulthood: An Interprofessional Mixed-Methods Study.重视成人X连锁低磷血症的经历:一项跨专业混合方法研究。
J Patient Cent Res Rev. 2020 Apr 27;7(2):176-188. doi: 10.17294/2330-0698.1727. eCollection 2020 Spring.
3
Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study.
探讨 X 连锁低磷血症的负担:一项欧洲多国定性研究。
Qual Life Res. 2020 Jul;29(7):1883-1893. doi: 10.1007/s11136-020-02465-x. Epub 2020 Mar 11.
4
Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia.X 连锁低磷血症成人的骨关节炎、骨赘和肌腱末端病影响生物力学功能。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1798-814. doi: 10.1210/clinem/dgaa064.
5
Fall prevention initiative: A fall screening and intervention pilot study on the ambulatory setting.防跌倒计划:门诊环境中的跌倒筛查和干预试点研究。
J Trauma Acute Care Surg. 2020 Jan;88(1):101-105. doi: 10.1097/TA.0000000000002514.
6
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.布罗索尤单抗可改善 X 连锁低磷血症成人的佝偻病组织形态计量学指标:一项 3 期、单臂、国际试验。
J Bone Miner Res. 2019 Dec;34(12):2183-2191. doi: 10.1002/jbmr.3843. Epub 2019 Oct 1.
7
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey.X连锁低磷血症的终身影响:疾病负担调查结果
J Endocr Soc. 2019 May 7;3(7):1321-1334. doi: 10.1210/js.2018-00365. eCollection 2019 Jul 1.
8
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.在 24 周双盲安慰剂对照期后继续治疗 24 周:X 连锁低磷血症成人中布罗索尤单抗的持续有益作用的结果。
Calcif Tissue Int. 2019 Sep;105(3):271-284. doi: 10.1007/s00223-019-00568-3. Epub 2019 Jun 4.
9
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.布罗索尤单抗治疗 X 连锁低磷血症儿童:一项随机、活性药物对照、开放标签、3 期临床试验。
Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16.
10
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.X 连锁低磷血症的诊断和管理临床实践建议。
Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5.